Skip to main content
Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
26.89
+1.49 (5.87%)
At close: Dec 5, 2025, 4:00 PM EST
26.88
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:59 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2011 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
Transformative Cell and Exosome-based Therapeutics
22.27M
Log In
Log In
Log In
Log In
Upgrade
Transformative Cell and Exosome-based Therapeutics Growth
-11.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2011 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
United States
22.27M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-11.55%
Log In
Log In
Log In
Log In
Upgrade